These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 17184784)
1. Development of an on-line high performance liquid chromatography detection system for human cytochrome P450 1A2 inhibitors in extracts of natural products. Jeurissen SM; Claassen FW; Havlik J; Bouwmans EE; Cnubben NH; Sudhölter EJ; Rietjens IM; van Beek TA J Chromatogr A; 2007 Feb; 1141(1):81-9. PubMed ID: 17184784 [TBL] [Abstract][Full Text] [Related]
3. Development of a novel cytochrome p450 bioaffinity detection system coupled online to gradient reversed-phase high-performance liquid chromatography. Kool J; van Liempd SM; Ramautar R; Schenk T; Meerman JH; Irth H; Commandeur JN; Vermeulen NP J Biomol Screen; 2005 Aug; 10(5):427-36. PubMed ID: 16093552 [TBL] [Abstract][Full Text] [Related]
4. Development of three parallel cytochrome P450 enzyme affinity detection systems coupled on-line to gradient high-performance liquid chromatography. Kool J; van Liempd SM; van Rossum H; van Elswijk DA; Irth H; Commandeur JN; Vermeulen NP Drug Metab Dispos; 2007 Apr; 35(4):640-8. PubMed ID: 17251308 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Unger M; Frank A Rapid Commun Mass Spectrom; 2004; 18(19):2273-81. PubMed ID: 15384148 [TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 bio-affinity detection coupled to gradient HPLC: on-line screening of affinities to cytochrome P4501A2 and 2D6. Kool J; van Liempd SM; Harmsen S; Beckman J; van Elswijk D; Commandeur JN; Irth H; Vermeulen NP J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):49-58. PubMed ID: 17826363 [TBL] [Abstract][Full Text] [Related]
7. Preparation, purification, and spectrophotometric characterization of cytochrome P450 1A2 conjugated with polyethylene glycol monomethyl ether. Nakhgevany R; Bonsu O; Barber J; Mabrouk PA; Ueng YF; Bell LC; Guengerich FP Biochem Biophys Res Commun; 1996 May; 222(2):406-9. PubMed ID: 8670218 [TBL] [Abstract][Full Text] [Related]
9. Isoform-selective inhibition of chrysin towards human cytochrome P450 1A2. Kinetics analysis, molecular docking, and molecular dynamics simulations. He L; He F; Bi H; Li J; Zeng S; Luo HB; Huang M Bioorg Med Chem Lett; 2010 Oct; 20(20):6008-12. PubMed ID: 20832301 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of human liver cytochrome P-450 1A2 by the class IB antiarrhythmics mexiletine, lidocaine, and tocainide. Wei X; Dai R; Zhai S; Thummel KE; Friedman FK; Vestal RE J Pharmacol Exp Ther; 1999 May; 289(2):853-8. PubMed ID: 10215663 [TBL] [Abstract][Full Text] [Related]
11. Validation of a high-performance liquid chromatography assay for quantification of caffeine and paraxanthine in human serum in the context of CYP1A2 phenotyping. Koch JP; ten Tusscher GW; Koppe JG; Guchelaar HJ Biomed Chromatogr; 1999 Jun; 13(4):309-14. PubMed ID: 10416066 [TBL] [Abstract][Full Text] [Related]
12. Screening of complex natural extracts by countercurrent chromatography using a parallel protocol. Lu Y; Berthod A; Hu R; Ma W; Pan Y Anal Chem; 2009 May; 81(10):4048-59. PubMed ID: 19331393 [TBL] [Abstract][Full Text] [Related]
13. Analysis of frankincense from various Boswellia species with inhibitory activity on human drug metabolising cytochrome P450 enzymes using liquid chromatography mass spectrometry after automated on-line extraction. Frank A; Unger M J Chromatogr A; 2006 Apr; 1112(1-2):255-62. PubMed ID: 16364338 [TBL] [Abstract][Full Text] [Related]
14. Screening of xanthine oxidase inhibitors in complex mixtures using online HPLC coupled with postcolumn fluorescence-based biochemical detection. Li D; Li S; Zhao J J Sep Sci; 2014 Feb; 37(4):338-44. PubMed ID: 24347507 [TBL] [Abstract][Full Text] [Related]
15. Metabolic profiling of endocrine-disrupting compounds by on-line cytochrome p450 bioreaction coupled to on-line receptor affinity screening. Van Liempd SM; Kool J; Meerman JH; Irth H; Vermeulen NP Chem Res Toxicol; 2007 Dec; 20(12):1825-32. PubMed ID: 17975887 [TBL] [Abstract][Full Text] [Related]
16. Kava does not display metabolic toxicity in a homogeneous cellular assay. Zou L; Harkey MR; Henderson GL; Dike LE Planta Med; 2004 Apr; 70(4):289-92. PubMed ID: 15095141 [TBL] [Abstract][Full Text] [Related]
17. Human cytochrome p450 enzyme specificity for the bioactivation of estragole and related alkenylbenzenes. Jeurissen SM; Punt A; Boersma MG; Bogaards JJ; Fiamegos YC; Schilter B; van Bladeren PJ; Cnubben NH; Rietjens IM Chem Res Toxicol; 2007 May; 20(5):798-806. PubMed ID: 17407329 [TBL] [Abstract][Full Text] [Related]
18. Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors. Korhonen LE; Rahnasto M; Mähönen NJ; Wittekindt C; Poso A; Juvonen RO; Raunio H J Med Chem; 2005 Jun; 48(11):3808-15. PubMed ID: 15916432 [TBL] [Abstract][Full Text] [Related]
19. Composition and biological activity of traditional and commercial kava extracts. Côté CS; Kor C; Cohen J; Auclair K Biochem Biophys Res Commun; 2004 Sep; 322(1):147-52. PubMed ID: 15313185 [TBL] [Abstract][Full Text] [Related]
20. Rapid determination of six metabolites from multiple cytochrome P450 probe substrates in human liver microsome by liquid chromatography/mass spectrometry: application to high-throughput inhibition screening of terpenoids. He F; Bi HC; Xie ZY; Zuo Z; Li JK; Li X; Zhao LZ; Chen X; Huang M Rapid Commun Mass Spectrom; 2007; 21(5):635-43. PubMed ID: 17279482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]